Eupraxia Pharmaceuticals (EPRX) Earnings Date, Estimates & Call Transcripts $5.36 -0.06 (-1.09%) As of 03:16 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Eupraxia Pharmaceuticals Earnings Summary Eupraxia Pharmaceuticals announced Q1 2025 earnings on May 6, 2025, reporting an EPS of -$0.21, which missed the consensus estimate of -$0.19 by $0.02. With a trailing EPS of -$0.76, Eupraxia Pharmaceuticals' earnings are expected to grow next year, from ($0.67) to ($0.60) per share. Q1 2025 Earnings ResourcesQ1 2025 Earnings ReportLatest Q1 2025 Earnings DateMay. 6EstimatedConsensus EPS (May. 6) -$0.19 Actual EPS (May. 6) -$0.21 Missed By -$0.02 Get Eupraxia Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Eupraxia Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataEPRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Eupraxia Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ2 20251-$0.21-$0.21-$0.21Q3 20251-$0.18-$0.18-$0.18Q4 20251-$0.20-$0.20-$0.20 Eupraxia Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails5/6/2025Q1 2025-$0.19-$0.21 -$0.02-$0.21--3/20/2025Q4 2024-$0.20-$0.21 -$0.01-$0.21--11/7/2024---$0.17--$0.17--8/7/2024Q2 2024--$0.17--$0.17--5/8/2024Q1 2024--$0.21--$0.21--4/1/2024Q4 2023--$0.17--$0.17--11/14/2023Q3 2023--$0.26--$0.26--8/11/2023Q2 2023--$0.36--$0.36-- Eupraxia Pharmaceuticals Earnings - Frequently Asked Questions When did Eupraxia Pharmaceuticals announce their last quarterly earnings? Eupraxia Pharmaceuticals (NASDAQ:EPRX) last announced its quarterly earning data on Tuesday, May 6, 2025. Learn more on EPRX's earnings history. Did Eupraxia Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Eupraxia Pharmaceuticals (NASDAQ:EPRX) missed the analysts' consensus estimate of ($0.19) by $0.02 with a reported earnings per share (EPS) of ($0.21). Learn more on analysts' earnings estimate vs. EPRX's actual earnings. How much profit does Eupraxia Pharmaceuticals generate each year? Eupraxia Pharmaceuticals (NASDAQ:EPRX) has a recorded net income of -$25.50 million. EPRX has generated -$0.76 earnings per share over the last four quarters. What is Eupraxia Pharmaceuticals' EPS forecast for next year? Eupraxia Pharmaceuticals' earnings are expected to grow from ($0.67) per share to ($0.60) per share in the next year. More Earnings Resources from MarketBeat Related Companies Niagen Bioscience Earnings Results GH Research Earnings Results Vir Biotechnology Earnings Results AnaptysBio Earnings Results Amylyx Pharmaceuticals Earnings Results Day One Biopharmaceuticals Earnings Results Stoke Therapeutics Earnings Results KalVista Pharmaceuticals Earnings Results Mind Medicine (MindMed) Earnings Results atai Life Sciences Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Constellation Energy’s Earnings Beat Signals a New EraRealty Income Rallies Post-Earnings Miss—Here’s What Drove ItDon't Mix the Signal for Noise in Super Micro Computer's EarningsWhy Monolithic Power's Earnings and Guidance Ignited a RallyRivian Takes Earnings Hit—R2 Could Be the Stock's 2026 LifelinePalantir Stock Soars After Blowout Earnings ReportVertical Aerospace's New Deal and Earnings De-Risk Production This page (NASDAQ:EPRX) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eupraxia Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eupraxia Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EPRX Stock Alerts